138 related articles for article (PubMed ID: 18946956)
21. Immediate and unexplained fetal death during mid-trimester amniocentesis.
Shapiro LR; Singer N; Mannor SM
Prenat Diagn; 1983; 3(2):151-4. PubMed ID: 6684772
[TBL] [Abstract][Full Text] [Related]
22. [A complication of amniocentesis during second trimester of pregnancy. Case report].
Koleva Zh; Kostova S; Katsulov A; Savova S
Akush Ginekol (Sofiia); 2003; 42 Suppl 2():18-20. PubMed ID: 14619748
[TBL] [Abstract][Full Text] [Related]
23. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
Tovey LA; Taverner JM
Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
[TBL] [Abstract][Full Text] [Related]
24. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy.
Michel M; Novoa MV; Bussel JB
Br J Haematol; 2003 Oct; 123(1):142-6. PubMed ID: 14510957
[TBL] [Abstract][Full Text] [Related]
25. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
26. [A quantitative determination of IgG anti-D subclasses by Elisa in hemolytic disease of the newborn].
Achargui S; Benchemsi N
Transfus Clin Biol; 2003 Sep; 10(4):284-91. PubMed ID: 14563417
[TBL] [Abstract][Full Text] [Related]
27. Pregnancy outcome following amniocentesis at 11-14 versus 16-19 weeks' gestation.
Wilson RD; Johnson JA; Dansereau J
Obstet Gynecol; 1996 Oct; 88(4 Pt 1):638-9. PubMed ID: 8841234
[No Abstract] [Full Text] [Related]
28. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases.
Mazza V; Pati M; Bertucci E; Re C; Ranzi A; Percesepe A; Forabosco A; Volpe A
Prenat Diagn; 2007 Feb; 27(2):180-3. PubMed ID: 17238217
[TBL] [Abstract][Full Text] [Related]
29. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
Sainio S; Kuosmanen M
Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
[TBL] [Abstract][Full Text] [Related]
30. Fetal death secondary to needle laceration during 2nd trimester amniocentesis: a case report.
Stock RJ
Prenat Diagn; 1982 Apr; 2(2):133-7. PubMed ID: 7145840
[No Abstract] [Full Text] [Related]
31. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
Lubušký M; Procházka M; Simetka O; Holusková I
Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
[TBL] [Abstract][Full Text] [Related]
32. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
Huchet J; Brossard Y
Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
[No Abstract] [Full Text] [Related]
33. Lack of anti-D in women at birth following antepartum immune globulin prophylaxis.
Rudensky B; Mazaki E; Na'amad M; Samueloff A
Eur J Obstet Gynecol Reprod Biol; 2003 Mar; 107(1):45-6. PubMed ID: 12593893
[TBL] [Abstract][Full Text] [Related]
34. Needle puncture of fetus: a complication of second-trimester amniocentesis.
Broome DL; Wilson MG; Weiss B; Kellogg B
Am J Obstet Gynecol; 1976 Sep; 126(2):247-52. PubMed ID: 961765
[TBL] [Abstract][Full Text] [Related]
35. Risk factors predisposing to fetal loss following a second trimester amniocentesis.
Papantoniou NE; Daskalakis GJ; Tziotis JG; Kitmirides SJ; Mesogitis SA; Antsaklis AJ
BJOG; 2001 Oct; 108(10):1053-6. PubMed ID: 11702837
[TBL] [Abstract][Full Text] [Related]
36. Rh sensitization after genetic amniocentesis.
Hill LM; Platt LD; Kellogg B
Obstet Gynecol; 1980 Oct; 56(4):459-61. PubMed ID: 6775257
[TBL] [Abstract][Full Text] [Related]
37. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
38. Repeated severe neonatal hemolysis due to Rhesus isoimmunization in a pregnant woman.
Chen DC; Chang YK; Chen WH; Liu JY
J Formos Med Assoc; 2002 May; 101(5):359-61. PubMed ID: 12101855
[TBL] [Abstract][Full Text] [Related]
39. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
Howard HL; Martlew VJ; McFadyen IR; Clarke CA
Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694
[TBL] [Abstract][Full Text] [Related]
40. [Correlation between maternal anti-D antibody-mediated cytotoxicity and the severity of neonatal hemolytic disease].
Carbonell-Uberos F; Puig N; Jorquera J; Montero JM; Soler MA; Marty ML
Sangre (Barc); 1987; 32(4):423-7. PubMed ID: 3116687
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
